Willingness to switch to long-acting regimens among people with HIV: a systematic review and meta-analysis
Kyra F Mendes de Leon, Roos D Klungers, Pythia T Nieuwkerk, Marc Van Der Valk · 2026
Read Willingness to switch to long-acting regimens among people with HIV: a systematic review and meta-analysis by Kyra F Mendes de Leon, Roos D Klungers, Pythia T Nieuwkerk, Marc Van Der Valk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13566456.txt.
Description
Kyra F. Mendes de Leon and colleagues asked how many people with HIV would trade daily pills for long-acting treatment. Long-acting regimens, such as injections every two months, promise more freedom and convenience, but clinics need to know whether patients actually want them. Their systematic review and meta-analysis searched PubMed and Embase to October 2024 and pooled 22 studies, nearly all from Europe or North America.
About 70 percent of participants said they would switch to some long-acting option, and 60 percent would accept two-monthly injections, the most studied form. No study feature explained why willingness varied so much between studies, suggesting preferences depend heavily on local context. Evidence on alternatives such as implants, tablets, and infusions remains thin, the authors note.
Catalog record
| CREATOR | Kyra F Mendes de Leon, Roos D Klungers, Pythia T Nieuwkerk, Marc Van Der Valk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |